SCHEMBL9076809

SCHEMBL9076809

O=C(O)NC(COCc1ccccc1)C(=O)N1CCCC1CNC(=O)CCCNC(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.47
DPP8 Q6V1X1 2/20 0.47
DPP9 Q86TI2 1/20 0.47
DPP7 Q9UHL4 1/20 0.47
PRCP P42785 1/20 0.46
HTT P42858 1/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42
ACE P12821 1/20 0.42
PREP P48147 6/20 0.42
CAPN1 P07384 1/20 0.42
CAPN2 P17655 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
TGM2 P21980 1/20 0.40
FOLH1 Q04609 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9076807 1.00 DPP4 (0.47) DPP4DPP8DPP9DPP7PRCP
SCHEMBL9075684 0.84 HTT (0.54) DPP4DPP8DPP9DPP7PRCP
SCHEMBL9075679 0.84 HTT (0.54) DPP4DPP8DPP9DPP7PRCP
SCHEMBL9074543 0.84 F2 (0.60) TGM2
SCHEMBL9074541 0.84 F2 (0.60) TGM2
SCHEMBL9076357 0.83 ITGB3 (0.55) DPP4DPP8DPP9DPP7PRCP
SCHEMBL9076354 0.83 ITGB3 (0.55) DPP4DPP8DPP9DPP7PRCP
SCHEMBL9077040 0.80 F2 (0.54)
SCHEMBL9077037 0.80 F2 (0.54)
SCHEMBL8603071 0.75 DPP4 (0.58) DPP4DPP8DPP9DPP7ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583146-A Heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 US disclosed
EP-0623596-A1 N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-11-09 EP disclosed